scispace - formally typeset
A

Anna Vera D Verschuur

Researcher at Icahn School of Medicine at Mount Sinai

Publications -  6
Citations -  109

Anna Vera D Verschuur is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 2, co-authored 2 publications receiving 31 citations.

Papers
More filters
Journal ArticleDOI

Trained Immunity-Promoting Nanobiologic Therapy Suppresses Tumor Growth and Potentiates Checkpoint Inhibition.

TL;DR: It is shown that rationally designed nanobiologics can promote trained immunity and elicit a durable anti-tumor response either as a monotherapy or in combination with checkpoint inhibitor drugs.
Journal ArticleDOI

Ki-67 assessment of pancreatic neuroendocrine neoplasms: Systematic review and meta-analysis of manual vs. digital pathology scoring

TL;DR: In this article , the authors systematically reviewed all published studies on the subject of Ki-67 assessment in pancreatic NENs (PanNENs) employing digital image analysis (DIA) and found that the most common advantages of DIA were improvement in the standardization and reliability of KPI evaluation, as well as its speed and practicality, compared to the current gold standard approach of manual counts from captured images, which is cumbersome and time consuming.
Journal ArticleDOI

Status of Surveillance and Nonsurgical Therapy for Small Nonfunctioning Pancreatic Neuroendocrine Tumors.

TL;DR: In this article , a review summarizes the status of surveillance and nonsurgical management for small pancreatic neuroendocrine tumors, including factors that can guide management, including tumor size and grade.
Journal ArticleDOI

Retrospective evaluation of national MRI reporting quality for lateral lymph nodes in rectal cancer patients and concordance with prospective re-evaluation following additional training

T C Sluckin, +251 more
TL;DR: In this article , the presence and size of lateral lymph nodes (LLNs) are important factors influencing treatment decisions for rectal cancer, and awareness of the clinical relevance and describing LLNs in MRI reports is therefore essential.